PortfoliosLab logoPortfoliosLab logo
Alpha Teknova, Inc. (TKNO)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US02080L1026
CUSIP
02080L102
IPO Date
Jun 25, 2021

Highlights

Market Cap
$154.74M
Enterprise Value
$165.85M
EPS (TTM)
-$0.32
Total Revenue (TTM)
$40.52M
Gross Profit (TTM)
$13.44M
EBITDA (TTM)
-$12.22M
Year Range
$1.91 - $7.48
ROA (TTM)
-16.66%
ROE (TTM)
-25.09%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Alpha Teknova, Inc.

Often compared with TKNO:
TKNO vs. VIGIXTKNO vs. BBAI

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alpha Teknova, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Alpha Teknova, Inc. (TKNO) has returned -23.95% so far this year and -44.32% over the past 12 months.


Alpha Teknova, Inc.

1D
7.84%
1M
12.02%
YTD
-23.95%
6M
-53.31%
1Y
-44.32%
3Y*
-0.79%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 25, 2021, TKNO's average daily return is -0.01%, while the average monthly return is +1.20%. At this rate, your investment would double in approximately 4.8 years.

Historically, 38% of months were positive and 62% were negative. The best month was Jul 2024 with a return of +174.5%, while the worst month was Mar 2023 at -45.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.

On a daily basis, TKNO closed higher 46% of trading days. The best single day was Jul 17, 2024 with a return of +42.2%, while the worst single day was Mar 10, 2023 at -21.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-36.32%6.61%12.02%-23.95%
20255.87%-26.47%-20.15%28.52%-13.49%-14.90%-7.94%-4.42%43.29%-15.19%-10.86%-18.80%-54.49%
2024-13.94%-10.59%-7.67%-32.83%-1.12%-22.16%174.45%31.38%-2.02%40.50%9.85%11.78%123.86%
20235.67%-9.06%-45.39%-36.15%103.17%-30.47%26.97%-42.48%43.08%-28.67%2.51%82.84%-33.87%
2022-22.95%7.73%-18.76%-18.68%-31.88%9.80%-22.74%-30.51%-25.94%37.43%2.83%19.49%-72.46%
2021-5.08%-6.36%-14.45%30.93%-7.63%-2.74%-8.41%-18.08%

Benchmark Metrics

Alpha Teknova, Inc. has an annualized alpha of -15.72%, beta of 1.36, and R² of 0.06 versus S&P 500 Index. Calculated based on daily prices since June 28, 2021.

  • This stock participated in 144.44% of S&P 500 Index downside but only -40.28% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.06 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-15.72%
Beta
1.36
0.06
Upside Capture
-40.28%
Downside Capture
144.44%

Return for Risk

Risk / Return Rank

TKNO ranks 18 for risk / return — in the bottom 18% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


TKNO Risk / Return Rank: 1818
Overall Rank
TKNO Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
TKNO Sortino Ratio Rank: 1616
Sortino Ratio Rank
TKNO Omega Ratio Rank: 1818
Omega Ratio Rank
TKNO Calmar Ratio Rank: 1919
Calmar Ratio Rank
TKNO Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Alpha Teknova, Inc. (TKNO) and compare them to a chosen benchmark (S&P 500 Index).


TKNOBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.58

0.90

-1.48

Sortino ratio

Return per unit of downside risk

-0.64

1.39

-2.02

Omega ratio

Gain probability vs. loss probability

0.93

1.21

-0.28

Calmar ratio

Return relative to maximum drawdown

-0.62

1.40

-2.02

Martin ratio

Return relative to average drawdown

-1.15

6.61

-7.76

Explore TKNO risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Alpha Teknova, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Alpha Teknova, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alpha Teknova, Inc. was 95.71%, occurring on Jul 5, 2024. The portfolio has not yet recovered.

The current Alpha Teknova, Inc. drawdown is 89.67%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.71%Jun 29, 2021759Jul 5, 2024

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alpha Teknova, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Alpha Teknova, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for TKNO relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TKNO has a P/S ratio of 3.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for TKNO in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TKNO has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items